参考文献/References:
[1] Soloviev D,Fini A, Chierichetti F,et al. PET imaging with 11C-acetate in prostate cancer:a biochemical, radiochemical and clinical perspective. Eur J Nucl Med Mol Imaging, 2008,35(5):942-949.
[2] Pike VW, Eakins MN, Allan RM, et al. Preparation of[l-11C] acetate-an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot, 1982,33(7):505-512.
[3] Luong A,Hannah VC, Brown MS, et al. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem, 2000, 275(34):26458-26466.
[4] Yoshimoto M, Waki A, Yonekura Y,et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation:acetate metabolism in tumor cells. Nucl Med Biol, 2001, 28(2):117-122.
[5] Yeh SH, Liu RS, Wu LC, et al. 11C-acetate clearance in nasopharyngeal carcinoma. Nucl Med Commun, 1999, 20(2):131-134.
[6] Dusing RW, Drisko JA, Grado GG, et al. Prostate imaging modalities that can be used for complementary and alternative medicine clinical studies. Urol Clin North Am, 2011, 38(3):343-357.
[7] Oyama N, Kim J, Jones LA, et al. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model. Nucl Med Biol, 2002, 29(8):783-790.
[8] Jana S, Blaufox MD. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med, 2006, 36(1):51-72.
[9] Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med, 2004, 34(4):274-292.
[10] Oyama N, Miller TR, Dehdashti F, et al. 11C-acetate PET imaging of prostate cancer:detection of recurrent disease at PSA relapse. J Nucl Med, 2003, 44(4):549-555.
[11] Fricke E, Machtens S,Hofmann M, et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging, 2003, 30(4):607-611.
[12] Mena E, Turkbey B, Mani H, et al. 11C-Acetate PET/CT in localized prostate cancer:a study with MRI and histopathologic correlation. J Nucl Med, 2012,53(4):538-545.
[13] Sepp?l? J, Sepp?nen M, Arponen E, et al. Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. Radiother Oncol, 2009, 93(2):234-240.
[14] Kato T, Tsukamoto E, Kuge Y, et al. Accumulation of[11C] acetate in normal prostate and benign prostatic hyperplasia:comparison with prostate cancer. Eur J Nucl Med Mol Imaging, 2002, 29(11):1492-1495.
[15] Ho CL, Yu SC, Yeung DW. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med, 2003, 44(2):213-221.
[16] Salem N, Kuang Y, Wang F, et al. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose,[1-11C]-acetate and[N -methyl-11C]-choline. Q J Nucl Med Mol Imaging, 2009, 53(2):144-156.
[17] Park JW, Kim JH, Kim SK, et al. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med, 2008,49(12):1912-1921.
[18] Cheung TT, Chan SC, Ho CL, et al. Can positron emission tomography with the dual tracers[11C] acetate and[18F] fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma. Liver Transpl, 2011,17(10):1218-1225.
[19] Magini G, Farsad M, Frigerio M, et al. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med, 2009, 34(10):659-665.
[20] Lhommel R, Annet L, Bol A, et al. PET scan with 11C-acetate for the imaging of liver masses:report of a false positive case. Eur J Nucl Med Mol Imaging, 2005, 32(5):629.
[21] Yamamoto Y, Nishiyama Y, Kimura N, et al. 11C-acetate PET in the evaluation of brain glioma:comparison with 11C-methionine and 18F-FDG-PET. Mol Imaging Biol, 2008,10(5):281-287.
[22] Liu RS, Chang CP, Guo WY, et al. l-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med, 2010, 51(6):883-891.
[23] Shreve P, Chiao PC, Humes HD, et al. Carbon-11-acetate PET imaging in renal disease. J Nucl Med, 1995, 36(9):1595-1601.
[24] Oyama N, Okazawa H, Kusukawa N, et al. 11C-Acetate PET imaging for renal cell carcinoma. Eur J Nucl Med Mol Imaging, 2009, 36(3):422-427.
[25] Kotzerke J, Linné C, Meinhardt M, et al.[1-11C] Acetate uptake is not increased in renal cell carcinoma. Eur J Nucl Med Mol Imaging, 2007, 34(6):884-888.
[26] Ho CL, Chen S, Ho KM, et al. 11C-acetate PET/CT in multicentric angiomyolipoma of the kidney. Clin Nucl Med, 2011, 36(5):407-408.
[27] Orevi M, Klein M, Mishani E, et al. 11C-acetate PET/CT in bladder urothelial carcinoma:intraindividual comparison with 11C-choline. Clin Nucl Med, 2012, 37(4):e67-72.
[28] Sun A, S?rensen J, Karlsson M, et al. 1-[11C]-acetate PET imaging in head and neck cancer-a comparison with 18F-FDG-PET:implications for staging and radiotherapy planning. Eur J Nucl Med Mol Imaging, 2007, 34(5):651-657.
[29] Sun A, Johansson S, Turesson I,et al. Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using l-[11C]-acetate PET during radiotherapy:preliminary results. Int J Radiat Oncol Biol Phys, 2012, 82(2):554-560.
[30] Nomori H, Shibata H, Uno K, et al. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma. J Thorac Oncol, 2008, 3(12):1427-1432.
[31] Shibata H,Nomori H, Uno K, et al. 11C-acetate for positron emission tomography imaging of clinical stage IA lung adenocarcinoma:comparison with 18F-fluorodeoxyglucose for imaging and evaluation of tumor aggressiveness. Ann Nucl Med, 2009, 23(7):609-616.
[32] Higashi K, Ueda Y, Matsunari I, et al. 11C-acetate PET imaging of lung cancer:comparison with 18F-FDG PET and 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging, 2004, 31(1):13-21.
[33] Kaji M, Nomori H, Watanabe K, et al. 11C-acetate and 18F-fluo-rodeoxyglucose positron emission tomography of pulmonary adeno-carcinoma. Ann Thorac Surg, 2007, 83(1):312-314.
[34] Lee SM, Kim TS, Lee JW, et al. Incidental finding of an 11C-acetate PET-positive multiple myeloma. Ann Nucl Med,2010, 24(1):41-44.
[35] Sakurai H, Kaji M, Suemasu K. Thymoma of the middle mediastinum:11C-acetate positron emission tomography imaging. Ann Thorac Surg, 2009, 87(4):1271-1274.
[36] Shreve PD, Gross MD. Imaging of the pancreas and related diseases with PET carbon-11-acetate. J Nucl Med, 1997, 38(8):1305-1310.
相似文献/References:
[1]张奇洲,李毓斌,李肖红,等.11C-乙酸盐的自动化合成影响因素的考察及质量控制[J].国际放射医学核医学杂志,2016,40(1):6.[doi:10.3760/cma.j.issn.1673-4114.2016.01.002]
Zhang Qizhou,Li Yubin,Li Xiaohong,et al.Study of the automated synthesis influence factors and quality control of 11C-acetate[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):6.[doi:10.3760/cma.j.issn.1673-4114.2016.01.002]
[2]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[3]王振光,王洋洋.PET/CT显像在肝细胞肝癌诊断中的研究进展[J].国际放射医学核医学杂志,2015,39(2):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
Wang Zhenguang,Wang Yangyang.The development of PET/CT imaging in the diagnosis of hepatocellular carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):175.[doi:10.3760/cma.j.issn.1673-4114.2015.02.016]
[4]展凤麟,汪世存,潘博,等.11C-胆碱和18F-FDG PET/CT显像在脑胶质瘤诊断中的应用[J].国际放射医学核医学杂志,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
ZHAN Feng-lin,WANG Shi-cun,PAN Bo,et al.Application of 11C-choline and 18F-FDG PET/CT in diagnosing brain glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
[5]谢燃,李琳,邓智勇,等.18F-FDG耳关合11C-乙酸盐PET-CT在肝癌诊断中的应用[J].国际放射医学核医学杂志,2011,35(3):167.[doi:10.3760/cma.j.issn.1673-4114.2011.03.008]
XIE Ran,LI Lin,DENG Zhi-yong,et al.The applications of 18F-FDG combined with 11C-acetate PET-CT imaging in the diagnosis of hepatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):167.[doi:10.3760/cma.j.issn.1673-4114.2011.03.008]
[6]李亚军,张慧娟.放射性核素标记胆碱与18F-FDG PET肿瘤显像的对比研究[J].国际放射医学核医学杂志,2010,34(6):348.[doi:10.3760/cma.j.issn.1673-4114,2010.06.007]
LI Ya-jun,ZHANG Hui-juan.Comparison choline with 18F-FDG PET in various tumors imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):348.[doi:10.3760/cma.j.issn.1673-4114,2010.06.007]
[7]罗作明,吴华.PET代谢显像剂11C-乙酸盐在临床中的应用[J].国际放射医学核医学杂志,2007,31(1):25.
LUO Zuo-ming,WU Hua.Clinical application of 11C-acetate PET metabolism imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):25.
[8]张锦明,田嘉禾,刘伯里.影响PET放射性药物11C甲基化的因素[J].国际放射医学核医学杂志,2006,30(5):271.
ZHANG Jing-ming,TIAN Jia-he,LIU Bo-li.Influence factor on 11C methylation in PET radiopharmaceuticals[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):271.
[9]麻广宇,刘家金,徐白萱,等.11C-乙酸盐PET/CT显像在中、高分化肝细胞肝癌复发与转移监测中的应用研究[J].国际放射医学核医学杂志,2018,(4):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
Ma Guangyu,Liu Jiajin,Xu Baixuan,et al.Application of 11C-acetate PET/CT imaging in the detection of recurrence and metastasis of hepatocellular carcinoma with intermediate and high differentiation[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(4):312.[doi:10.3760/cma.j.issn.1673-4114.2018.04.004]
[10]赵雷,杨雁,孙华.自动化固相萃取法合成11C-乙酸盐的影响因素[J].国际放射医学核医学杂志,2015,39(3):224.[doi:10.3760/cma.j.issn.1673-4114.2015.03.008]
Zhao Lei,Yang Yan,Sun Hua.Influential factors of solid-phase extraction method to automate the synthesis of 11C-acetate[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):224.[doi:10.3760/cma.j.issn.1673-4114.2015.03.008]
[11]马文超,徐文贵.11C-乙酸盐在肿瘤PET或PET-CT中的应用[J].国际放射医学核医学杂志,2011,35(1):23.[doi:10.3760/cma.j.issn.1673-4114.2011.01.007]
MA Wen-chao,XU Wen-gui.The application of 11C-acetate PET or PET-CT for tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):23.[doi:10.3760/cma.j.issn.1673-4114.2011.01.007]